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Abstract
Radiation therapy, which uses X-rays to destroy or injure cancer cells, has become one of the most
important modalities to treat the primary cancer or advanced cancer. High resolution, water equivalent
and passive X-ray dosimeters are highly desirable for developing quality assurance (QA) systems for
novel cancer therapy like microbeam radiation therapy (MRT) which is currently under development. Here
we present the latest developments of high spatial resolution scintillator based photonic dosimeters, and
their applications to clinical external radiation beam therapies: specifically high energy linear accelerator
(LINAC) photon beams and low energy synchrotron photon beams. We have developed optical fiber
dosimeters with spatial resolutions ranging from 50 to 500 mm and tested them with LINAC beams and
synchrotron microbeams. For LINAC beams, the fiberoptic probes were exposed to a 6 MV, 10 cm by 10
cm Xray field and, the beam profiles as well as the depth dose profiles were measured at a source-tosurface distance (SSD) of 100 cm. We have also demonstrated the possibility for temporally separating
Cherenkov light from the pulsed LINAC scintillation signals. Using the 50 mm fiber probes, we have
successfully resolved the microstructures of the microbeams generated by the imaging and medical
beamline (IMBL) at the Australian Synchrotron and measured the peak-to-valley dose ratios (PVDRs). In
this paper, we summarize the results we have achieved so far, and discuss the possible solutions to the
issues and challenges we have faced, also highlight the future work to further enhance the performances
of the photonic dosimeters.

Disciplines
Engineering | Science and Technology Studies

Publication Details
Archer, J. & Li, E. (2018). Recent advances in photonic dosimeters for medical radiation therapy. Frontiers
of Optoelectronics, 11 (1), 23-29.

This journal article is available at Research Online: https://ro.uow.edu.au/eispapers1/1538

James ARCHER et al. Recent advances in photonic dosimeters for medical radiation therapy
Front. Optoelectron. (2017)
DOI

Recent advances in photonic dosimeters for medical
radiation therapy
James ARCHER, Enbang Li ()
Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW, Australia, 2522

© Higher Education Press and Springer-Verlag Berlin Heidelberg 2017
Abstract Radiation therapy, which uses X-rays to destroy or injure cancer cells, has become one of the most
important modalities to treat the primary cancer or advanced cancer. High resolution, water equivalent and
passive X-ray dosimeters are highly desirable for developing Quality Assurance (QA) systems for novel cancer
therapy like micro-beam radiation therapy (MRT) which is currently under development. Here we present the
latest developments of high spatial resolution scintillator based photonic dosimeters, and their applications to
clinical external radiation beam therapies: specifically high energy linear accelerator (LINAC) photon beams
and low energy synchrotron photon beams. We have developed optical fiber dosimeters with spatial resolutions
ranging from 50 m to 500 m and tested them with LINAC beams and synchrotron microbeams. For LINAC
beams, the fiber-optic probes were exposed to a 6 MV, 10 cm by 10 cm X-ray field and, the beam profiles as
well as the depth dose profiles were measured at a source-to-surface distance (SSD) of 100 cm. We have also
demonstrated the possibility for temporally separating Cherenkov light from the pulsed LINAC scintillation
signals. Using the 50 m fiber probes, we have successfully resolved the microstructures of the microbeams
generated by the Imaging and Medical Beamline (IMBL) at the Australian Synchrotron and measured the peakto-valley dose ratios (PVDRs). In this paper, we summarize the results we have achieved so far, and discuss the
possible solutions to the issues and challenges we have faced, also highlight the future work to further enhance
the performances of the photonic dosimeters.
Keywords fibre-optic dosimetry; scintillators; X-ray; cherenkov radiation; cancer therapy; micro-beam
radiation therapy
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Introduction

Photonic dosimetry is the use of photonic systems to measure radiation dose. There are several mechanisms for
generating photons from ionising radiation, the two most widely applied being scintillation light emission and
Cherenkov radiation. Originally pioneered by Sir William Crookes in 1903 [1], scintillation detectors have
found a wide variety of applications in the century following their discovery. Scintillators are materials that emit
visible light upon the absorption with ionising radiation. There are two main types of scintillators: organic (i.e.
hydrocarbon) and inorganic.
The light emission process for organic scintillators is caused by the valence electrons in the organic
molecules transitioning into higher singlet and triplet states upon the absorption of ionising radiation, and then
decaying back into the ground state, emitting photons. The singlet transitions emit scintillation photons very
quickly (within nanoseconds), while the triplet transitions are much slower, due to the necessity of a transition
from the lowest triplet state to an excited singlet state for photon emission [1]. Inorganic scintillators emit
photons via radiation interactions with a crystal electron band structure. Electron-hole pairs are generated
between the valence and conduction bands. Direct recombination results in the slow component of scintillation
light being emitted, while excitons (bound electron-hole pairs) recombine at impurity sites generating the fast
scintillation component [1].
Discovered by Pavel Cherenkov in 1934, Cherenkov radiation is a phenomenon whereby optical light is
radiated by charged particles moving though a medium faster than the speed of light in that medium [2]. The
Cherenkov radiation is generated in a cone, whose axis is along the direction of the particle’s velocity, with
angle defined by
1/ , where is the refractive index of the medium and is the ratio of the particle
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speed to that of light. The intensity of the Cherenkov radiation is proportional to
bluer wavelengths.

and hence dominates in the

Both scintillation light and Cherenkov light can be used for photonic dosimetry, under certain conditions. By
collecting the light generated, and measuring with a photodetector, the relative radiation dose can be
determined, and then with calibration against a standard device (such as an ionisation chamber) the absolute
dose can be measured. Scintillator detectors have been used in a wide variety of applications, such as radiation
contamination metering [3], neutrino detectors [4], and X-ray imaging [5] [6].
The dosimeter design by Beddar et al in 1993 is the foundational design that all later probes have built on [7]
[8]. They used plastic scintillator (a type of organic scintillator where the scintillator molecules are set in a
plastic base) cylinder, of length 4 mm and diameter 1 mm, coupled to a fiber optic of the same diameter, to
create a dosimetry probe of sensitive volume 3.14 mm3. The most important results from their design is the
probe is linear, energy independent and water equivalent. By being both linear in light output compared to
absorbed energy, and the total photon output being independent of the energy of incident radiation, the
dosimeter response scales in proportion to the absorbed dose. Once the dosimeter is calibrated against a standard
(an ionisation chamber for example) the dosimeter response is easily converted to absorbed dose.
A dosimeter being water equivalent simply means that the materials of the dosimeter interact with ionising
radiation the same that water does. As tissue is the material of interest in clinical radiotherapy, where these high
spatial resolution dosimeters are applied, the similarities of tissue to water mean that a dosimeter which is water
equivalent requires no further calibration to relate the measured dose to the absorbed dose in tissue. As
scintillators are water-equivalent in electron and photon radiation beams [9], this is a major advantage of plastic
scintillator photonic dosimeters over other dosimeters.
Cherenkov light has been used for dosimetric purposes. Clinical imaging of radiotracers takes advantage of
Cherenkov light, and provides a compliment to positron emission tomography imaging [10]. Electron beam
relative dosimetry has also been performed using Cherenkov light and showed favorable results [11] [12].
However, when a separate light source is being measured (for example in scintillator dosimetry) any Cherenkov
light generated will contaminate the light signal intended to be measured. This can negatively affect both the
total dose being measured and the spatial resolution of the dosimeter. For these reasons, Cherenkov light is
considered a source of noise in scintillator dosimetry, and needs to be accounted for. Cherenkov light is
generated in water and plastic. The standard method of Cherenkov removal in the field of scintillator dosimetry,
introduced by Beddar et al [7] [8], uses a parallel probe, but without the scintillator, allowing only the
Cherenkov light to be detected. This allows the Cherenkov signal to be subtracted from the contaminated
scintillator signal. This is accurate only in fields of low dose gradient. Furthermore, an arrayed probe system
would require photo-detection for each pair of scintillator and Cherenkov probes, which would quickly grow
cumbersome. Alternate methods for Cherenkov removal have been developed, such as optical filtration [13]
[14], spectral separation [15] [16] and temporal filtration [17] [18]. An in-depth review on these methods is
provided by Beaulieu and Beddar [9].
In this work we present the development of high spatial resolution scintillator based photonic dosimeters, and
their applications to clinical external radiation beam therapies: specifically high energy linear accelerator
(LINAC) photon beams and low energy synchrotron photon beams. LINAC beams have macroscopic field sizes
of square centimeters, and do not require a very high spatial resolution for accurate dosimetry. The challenging
regions to measure dose in are the edges of the field (the penumbra). Ionisation chambers are the standard for
this type of dosimetry, which provide very accurate dose measurements, but require sensitive calibrations to
temperature and pressure. Plastic scintillator dosimeters have been demonstrated to have a very low temperature
dependence and no pressure dependence [7].
Synchrotron microbeam radiation therapy (MRT) is a novel type of external beam radiation therapy currently
being investigated for its potential applications in treating children with brain tumors. Current therapies risk
damage to nervous system development, whereas in MRT the survivability of healthy tissue is much greater [19]
[20] [21] [22]. MRT uses high flux X-rays of typical mean energy 70 keV, which are spatially fractionated into
planes of thickness 50 m with separation 400 m. A major challenge of using MRT clinically is the difficulty
posed by the need for a high spatial resolution dosimeter to accurately measure the dose deposited across the
microbeams. Currently there are two important measurements to be made of the microbeams for quality
assurance (QA) purposes: the peak to valley dose ratio (PVDR), and the microbeam widths [23]. Measuring
these quantities ensures the dose is being deposited in the correct places, with maximum sparing in the valleys.
Current methods for microbeam QA use radiochromic film, single crystal diamond dosimeters (SCDDs) or
silicon strip detectors (SSDs). Film results are water equivalent, but take time to develop and scan, so do not
provide real time dosimetry. The spatial resolution of film is also limited by the film grain size, and the

microbeam widths fall below the nominal resolution recommendations of most commercial films [24]. SCDDs
and SSDs boast a practical resolution for microbeam dosimetry, but lack water equivalence [25] [26] [27]. A
crystal scintillator dosimeter has been demonstrated, but this device also lacks water equivalence [28]. We
believe a photonic dosimeter has the potential to be applied to MRT QA, as the plastic scintillator dosimeters are
water equivalent, have the spatial resolution to resolve microbeams, and can provide real time dosimetry.
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Photonic dosimeter designs and tests

We present photonic dosimeters that use BC-400 plastic scintillator (Saint-Gobain Crystals) coupled to a 1 mm
diameter optical fiber (Eska CK-40). To improve light capture the tip of the probe was coated in BC-620 (SaintGobain Crystals) reflective TiO2 paint (a diagram of the probe is shown in Fig. 1). With this design, three probes
were made, with differing thicknesses of plastic scintillator. The thickness of the scintillator defines the onedimensional spatial resolution of the probe. Thicknesses of 100 m and 50 m were used, defining sensitive
volumes of 0.079 mm3 and 0.039 mm3 respectively. A 500 m probe was also fabricated using BC-444
scintillator (with a slower rise time than the BC-400) to test a method for temporal separation of Cherenkov
light being developed [29].
The 100 m probe was tested using a Varian LA1-EX Clinical LINAC (CLINAC), at the Illawarra Cancer
Care Centre, Wollongong Hospital, Wollongong, Australia. Two methods for background subtraction were used
and tested: a secondary Cherenkov probe, and a temporal processing method being developed. The light was
collected with two RCA-4526 PMTs, and recorded using a Siglent SDS1102CML digital oscilloscope. The
sampling was done at 500 MHz, and at 1 GHz for the temporal separation process. The waveform of the light
pulses was recorded for the duration of the 3.5 s CLINAC pulses. To remove noise (from the PMT) in the
signal, 128 CLINAC pulses were sampled and averaged on the oscilloscope. To test repeatability four
measurements were taken at each position, allowing a 95% confidence interval to be calculated. The CLINAC
was configured to pulse 6 MV photons (peak energy 6 MeV, average energy 2 MeV) in a 10 × 10 cm2 field, a
typical therapeutic configuration. To assess the accuracy of the scintillator probe, results were compared to a
PinPoint N31014 ionization chamber (IC), under identical bam conditions.
The temporal separation method being developed relies on the Cherenkov light being detected before the
scintillation signal has saturated. This, in theory, allows the Cherenkov contribution to be characterized and
removed from the total signal.
A beam profile was measured at 15 mm depth in Solid Water (Gammex) and a percent depth dose (PDD) was
measured at depths varying from surface to 20 cm. The CLINAC beam profile (Fig. 2) and depth dose (Fig. 3)
are in close agreement with the ionization chamber data. Important beam qualities can be calculated from the
100 m probe data, which we compare to expected results. The distance for the field strength to drop from 80%
to 20% (the penumbra) was measured with the 100 m probe as (4.5 ± 0.7) cm for the left side and (5.0 ± 0.7)
cm for the right side. For the IC data, the penumbra is expected to be (0.545 ± 0.005) cm. The depth where the
maximum dose is deposited (dmax) was measured to be (1.2 ± 0.1) cm, which is expected to be 1.41 cm.

Fig. 1 Diagram of the dosimeter probe. Figure modified from Archer et al [30].

Fig. 2 Left, the CLINAC beam profile measured with the fiber optic dosimeter probe (FOD), compared to ionization
chamber data. Reproduced from Archer et al [30]. Temporal separation results are shown on the right.

Fig. 3 Left, percent depth dose of the CLINAC beam measured with the fiber optic dosimeter probe (FOD), compared to
ionization chamber data. Reproduced from Archer et al [30]. Temporal separation results are show on the right.

The higher resolution 50 m probe was tested at the Imaging and Medical Beamline (IMBL) at the Australian
Synchrotron, Clayton, Australia. The synchrotron X-rays were generated with a 2.0 T wiggler, have a mean
energy of 66 keV, and a typical dose rate of 120 Gy/s. A multi-slit collimator (MSC) can be inserted into the
broad beam to fractionate the X-rays into microbeams, of width 50 m and peak-to-peak separation 400 m.
The optical signal was measured and digitised by a SensL MiniSM Silicon Photomultiplier 10035 (SiPM)
connected to a Texas Instruments 64 channel analog front end (AFE0064). The light signal was integrated by
the AFE0064 over 200 s intervals at a frequency of 2 kHz.
The beam profiles were measured by scanning the probe though the microbeams at 0.1 mm/s. The results are
compared to a SSD developed by the Centre for Medical Radiation Physics, University of Wollongong,
Wollongong, Australia [25] [27]. The SSD has the same resolution (50 m) as the scintillator probe. The results
are shown in Fig. 4. A PDD was also measured in broad beam (without the MSC in place), by scanning the
probe through the field at two speeds: 5 mm/s and 10 mm/s, and integrating the net signal during the scan. This
was compared to a PinPoint N31014 IC, shown in Fig. 5.

Fig. 4 Microbeam profile measured with the 50 m probe (a) and the SSD (b). Insets show the same three microbeams in
closer detail. Reproduced from Archer et al [31].

Fig. 5 Percent depth dose plots, measured with the fiber optic dosimeter (FOD) at scanning speeds of 10 mm/s (a) and 5
mm/s (b). Ionization chamber (IC) results are also shown. Reproduced from Archer et al [31].
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Disscussion

There is a general agreeement betweeen the scintilllator probes and
a the ionisattion chamber data. There are
a several
factors thhat affect thee fluctuations and discrepaancies that can
n be seen between the dat
ata sets. The ionization
chamber results, whilee measured in
n the same beaam conditionss as the FOD data, was nott measured att the same
time, andd so could be
b responsiblee in part for discrepanciess present. Thee high voltagge supply of the PMT
measurinng the photon response also
o drifts througghout the duraation of the measurements, altering the gain
g of the
PMTs. T
This was correected for using
g the baselinee response outtside the field on either sidee, but fluctuattions on a
shorter tiime scale cannnot be correected for usinng this metho
od. The 500m probe resuults, with the temporal
Cherenkoov separation algorithm, have
h
much larrger uncertain
nties than the 100 m proobe, despite having
h
the
much larrger sensitive volume and hence
h
light ouutput. This is due
d to the sep
paration algoriithm being lesss reliable
than the simpler background subtraaction, indicatting that the method
m
requirres more deveelopment. The primary
difficultyy in applying the algorithm
m is that it asssumes the Ch
herenkov lightt during the ppulse quickly reaches a
maximum
m, and then stays
s
constantt for the rest of the pulse. However meeasurements oof the pure Cherenkov
C
signal inndicates that itt rises by up to 20% moree on a slowerr time scale. The next stepps for this wo
ork are to
improve the analysis by
b both adding
g in extra paraameters to fit to the model (such as the ttail of the pulse) and to
possibly characterize the
t Cherenkov
v pulse in morre detail with a separate Ch
herenkov meassurement, whiich can be
applied too all subsequeent measurements on the saame CLINAC machine.
The 1000 m results fluctuate arou
und the expeccted IC data. The
T most sign
nificant factorr in why this happens
h
is
the PMT
Ts gain fluctuaating over the approximatelly hour long data
d collection
n. This is the pprimary reaso
on a SiPM
was usedd for the MRT
T measurements. The amoount of Cheren
nkov light geenerated comppared to the scintillator
s
light wass very high, suggesting thaat the 100 m
m probe is the highest practical resolutionn achievable for 6 MV
photon beams with thee photonic dosimeter. This resolution is higher than reequired, as the
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wever for MR
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lower PV
VDR indicatess that the valley dose beingg measured is overestimated, as can be sseen in Fig. 4. Figure 5

shows there is a consistent discrepancy between the scintillator probe and IC response at 10 mm depth. Potential
explanations include the possible non-water equivalence or energy independence at low energies and
unaccounted for nonlinear Cherenkov or fluorescence effects.
The next steps for the high resolution photonic dosimeters for MRT is to test the limits of the spatial
resolution achievable with thinner scintillator, and to improve the light collection. A recent experiment has
demonstrated the ability of a 20 μm probe to resolve microbeams, and a 10 μm probe is being planned. A study
will be done on the optimal combination of scintillator type and photomultiplier, so as to match the scintillation
spectrum with the detection efficiency spectrum to get the total photon detection efficiency as best as possible.
The BC-620 paint compromises the water equivalence of the probe, as the titanium atoms have a much higher
effective Z number than water. At the thicknesses on the order of hundreds of microns, the paint will scatter the
incident radiation more than the plastic, and so will result in both an increase in captured light (the intended
effect) as well as an increase in the deposited dose in the scintillator (reducing the water equivalence of the
probe). For this reason we intend on investigating the necessity of the paint, as well as alternative, lower Z and
much thinner paint or reflective surface options, such as aluminum coating.

4

Conclusion

The results demonstrate, as a proof of concept, the possibility for high spatial resolution photonic dosimeters to
be applied to MRT. This is the first water equivalent probe to be applied in this area, due to the significant
challenges presented by the low light output of the very small sensitive volume. These results justify the
fabrication and testing of even higher resolution probes for this application. The limits of LINAC dosimetry has
been reached with the current methods. We have also demonstrated the possibility for temporally separating
Cherenkov light from a pulsed LINAC beam, although the algorithm for this required more work to be of a
clinical standard.
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